The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study
Related Experiment Videos
Insights
Oral anticoagulant therapy significantly increases intracerebral hemorrhage risk, especially in patients over 50. Hypertension is a key risk factor, with bleeding risk escalating with anticoagulation intensity.
Area of Science:
- Neurology
- Pharmacology
- Epidemiology
Background:
- Oral anticoagulant therapy is widely used for thromboembolic disease prevention.
- Intracerebral hemorrhage (ICH) is a serious complication of anticoagulant treatment.
- Understanding the risk factors and characteristics of anticoagulant-associated ICH is crucial for patient safety.
Purpose of the Study:
- To estimate the relative risk of intracerebral hemorrhage associated with oral anticoagulant therapy.
- To identify predisposing conditions and influencing factors for anticoagulant-associated ICH.
- To compare the clinical features and outcomes of anticoagulant-associated ICH with spontaneous ICH.
Main Methods:
- Retrospective study of 166 patients admitted to University Hospital, Leiden, The Netherlands (1970-1979).
- Estimation of relative risk of ICH in patients on oral anticoagulants compared to the general population.
- Analysis of patient demographics, predisposing conditions (especially hypertension), and anticoagulation intensity.
Main Results:
- Patients over 50 on oral anticoagulants had a >10-fold higher risk of ICH compared to untreated individuals.
- Hypertension was the most significant predisposing condition (80% of patients).
- Increased anticoagulation intensity correlated with a higher risk of bleeding; age and sex did not influence risk within the >50 group.
Conclusions:
- Oral anticoagulant therapy poses a substantial risk of intracerebral hemorrhage, particularly in older adults.
- Hypertension is a critical factor exacerbating this risk.
- Clinical presentation and outcomes of anticoagulant-associated ICH are similar to spontaneous ICH, emphasizing the need for careful anticoagulant management.
Abstract:
In a retrospective study of 166 patients, all admitted to the University Hospital, Leiden, The Netherlands, between January 1, 1970 and December 31, 1979, we estimated the relative risk of intracerebral hemorrhage from oral anticoagulant therapy. The risk was more than ten times higher for patients over 50 years of age than for similarly aged untreated individuals in the general population. Within this age group the risk was influenced by neither age nor sex. Hypertension, present in 80% of the patients, was the most important predisposing condition; the risk of bleeding rose with increasing intensity of anticoagulation. There was no substantial difference in clinical condition at onset, rate of progression, mortality, or degree of recovery between patients with anticoagulant-associated hemorrhage and those with spontaneous intracranial hemorrhage.